Approximately 19 million U.S. women of childbearing age reside in what are known as “contraceptive deserts” due to geographic, political, economic and social barriers to birth control. Women living in ...

Researchers evaluated the association between the use of various hormonal contraceptives and the risk for surgically treated intracranial meningioma.

Self-administered injectable contraceptives have been available in the United States for more than two decades, yet a new study has found only about a quarter of reproductive health experts prescribe ...

Researchers at Boston-based Mass General Brigham and MIT have developed a long-acting contraceptive injection designed to be delivered through tiny needles, reducing discomfort and increasing ...

Studies show Depo-Provera users have much higher relative risk of developing meningiomas, although overall risk remains low ...

Women in America and the United Kingdom are taking legal action against Pfizer and other birth control producers after a study indicated that injectable contraceptives were found to cause brain tumors ...

Self-administered injectable contraception has been available in the U.S. for more than two decades, yet a new study found that only about a quarter of reproductive health experts prescribe it — and ...

As part of an update to the CDC's practice recommendations on contraception, physicians are being encouraged to counsel patients on pain associated with intrauterine device (IUD) insertion. To ...

Barrier and hormonal contraception methods only temporarily prevent pregnancy. Once a person stops using these methods, the body’s natural fertility will typically resume. Sterilization methods, such ...

Self-injectable contraception is more commonly used globally, particularly in sub-Saharan Africa. It became more widely used in the U.S. during the COVID-19 pandemic, and the study found more than ...